Board of Directors
Mr. John Sharman
Mr. John Sharman has over 15 years of international business experience as Managing Director and Chief Executive Officer of public and private equity companies operating in Australia, the UK, Europe, Asia and the US. Presently, John is the CEO of Medical Devices International, a leading Australian pharmaceutical and medical device firm focused on emergency medicine. In the decade that John has led MDI, the company’s share price has risen from under 20 cents to exceed $8.50 … representing a compound return exceeding 45% per annum. John began his career in finance, with roles at PWC, National Australia Bank, and KPMG in London. He holds a B.Ec from Monash University and an M.App.Fin from Macquarie University.
Mr. Nicholas Weininger
Nicholas joined Anthrocell at its inception. He has a background in corporate finance practice working for KPMG and Andersen before joining a boutique corporate finance firm. Nicholas’ professional experience includes mergers and acquisitions, valuations of businesses, restructure, fund raising and general corporate advice associated with transactions and operations across a variety of business sizes and industries. In addition, he is a member of a number of private company boards and has acted as CFO and secretary to both public and listed organisations. Nicholas holds a Bachelor of Business degree with the University of Technology, a post graduate diploma in Applied Finance and Investment from the Securities Institute of Australia and is a member of the Society of Certified Practising Accountants.
Dr. Galina Kaseko
Dr. Kaseko is a co-founder and executive director of the Stephen Sanig Research Institute, an independent biotechnology research centre and a research partner of Anthrocell. Her career spans both industry and academia. As an entrepreneur and executive, she was involved in the establishment of three biotechnology firms, two of which had grown into publicly listed firms with valuations in excess of $100 million. She has extensive experience managing multi-disciplinary biological product development projects in a commercial environment, including hands-on experience in the design and implementation of clinical trials for human biologics and GMP/GLP implementation for therapeutic products. As an academic, she gave lectures and taught courses on biopharmaceuticals and immunology at the University of New South Wales, and has published several refereed journal articles and numerous conference presentations. Dr Kaseko received her B.Med.Sci. and M.D. with Distinction and Gold Medal from Moscow Medical University, and her Master’s Degree in Commercial and Intellectual Property Law from the University of New South Wales. She is an alumna of Harvard Business School‘s General Management Program.
H.E. Dr. Dr. Suwit Khunkitti
Dr. Khunkitti has an extensive base of experience and achievement spanning government, business, and social enterprises. Between 1983 and 2011 he served as a Member of Parliament and of The Government of Thailand, holding portfolios that included Minister of Science, Technology and Environment, Minister of Industry and Deputy Prime Minister. He served as Founding Chair of the APEC Life Sciences Innovation Forum Executive Board from 2003-2013, during which time he led the establishment of the Thailand Centre of Excellence for Life Sciences. Presently, he is working with several Asian investment groups to identify and manage investments in growth industries, including life sciences, sustainability and information technology. Dr. Khunkitti holds a PhD from the University of Technology Sydney, as well as a B.Sc and an M.Sc in Chemistry. He was awarded the J. Paul Getty Award for Conservation Leadership by the World Wildlife Fund.
Dr. Tohsak Mahaworasilpa
Dr Mahaworasilpa holds a Bachelor of Science degree from Chulalongkorn University, Bangkok, Thailand, a Master of Science in Medical Physics and a Doctor of Philosophy in Biophysics from the University of New South Wales. He is an innovative inventor and researcher in the areas of cell biophysics, immunology and biotechnology. His research interests in these fields include: the dynamics of biological cells in intense electric fields, the electrical properties of cell membranes, the effects of electric fields on the stability and survival of biological cells, the study of cell membrane breakdown, cell manipulation, stimulation and modification for the production of biopharmaceutical products which can be useful for prophylactic and therapeutic purposes (e.g. vaccines, human stimulating proteins), tissue culture of mammalian and plant cells. One of his groundbreaking researches in biological cell manipulation/modification has rendered him a holder of a world-wide patent, which laid the foundation for the development and commercialisation of a biotechnology company.